Jinglai Hao
6Patents
1h-index
38Co-inventors
43Inventor score
Filing activity: Jul 31, 2013 → Dec 11, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9527875B2 | Antidiabetic tricyclic compounds | Chemistry; Metallurgy | 3 | Active |
| US9828365B2 | Fused tetracyclic heterocyclic compounds and methods of use thereof for the treatment of viral diseases | Chemistry; Metallurgy | 0 | Active |
| US10646494B2 | Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases | Chemistry; Metallurgy | 0 | Active |
| US10864211B2 | Hydroxy isoxazole compounds useful as GPR120 agonists | Chemistry; Metallurgy | 0 | Active |
| US10787441B2 | Hepatitis C virus inhibitors | Human Necessities | 0 | Active |
| US10738062B2 | Chromane-substituted tetracyclic compounds and uses thereof for the treatment of viral diseases | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.